Penobscot Investment Management Company Inc. increased its position in shares of Eli Lilly and Company (NYSE: LLY) by 14.5% during the undefined quarter, according to its most recent filing with the S
Financiere des Professionnels Fonds d investissement inc. acquired a new stake in shares of Eli Lilly and Company (NYSE: LLY) in the undefined quarter, according to its most recent Form 13F filing wit
Synergy Asset Management LLC increased its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 101.9% during the third quarter, according to the company in its most recent disclosure with the S
Community Financial Services Group LLC lifted its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 13.4% in the third quarter, according to the company in its most recent filing with the Sec
Capital Advisors Inc. OK reduced its stake in Eli Lilly and Company (NYSE: LLY) by 13.7% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Ex
Ascent Wealth Partners LLC increased its stake in Eli Lilly and Company (NYSE: LLY) by 156.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Excha
Bank Pictet and Cie Europe AG lessened its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 1.9% in the third quarter, according to its most recent filing with the SEC. The firm owned 68,195
My Top 15 High-Growth Dividend Stock list delivered a 0.83% gain in December, outperforming SPY and VIG. The Value-tilted portfolio variant led with a 2.17% December return, suggesting undervaluation
Novo Nordisk cuts Wegovy prices in China, which may shift investor focus toward diversified healthcare ETFs.
Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.
Diversified Trust Co raised its holdings in Eli Lilly and Company (NYSE: LLY) by 16.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exc
Generate Investment Management Ltd boosted its stake in Eli Lilly and Company (NYSE: LLY) by 23.1% in the third quarter, according to the company in its most recent filing with the Securities and Exch
Calamos Advisors LLC cut its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 1.5% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Ex
Ascent Group LLC lifted its position in shares of Eli Lilly and Company (NYSE: LLY) by 3.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchang

Pfizer and GSK Lead 2026 U.S. Drug Price Hikes

11:03am, Wednesday, 31'st Dec 2025
Pfizer (PFE) and GlaxoSmithKline (GSK) are among the top drugmakers planning price increases for hundreds of branded medicines in the U.S. next year, according
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE